Mandate

Vinge advises Sertion in connection with the acquisition of Kiefer System Group

Vinge has advised Sertion AB (“Sertion”) in connection with the acquisition of Kiefer System Group.

The acquisition strengthens Sertion’s position as a leading international infra and piping partner in heating and sanitation projects, technical infrastructure, and industrial piping. Kiefer System Group, consisting of Kiefers System Svets Aktiebolag, Kiefer Systemtools AB and Uppsala Mekaniska Maskinbearbetning UMB AB, has unique expertise in orbital welding, special machinery, and on-site installations for the energy, pharmaceutical, and process industries.

Vinge’s team consisted of Christina Kokko, Desirée Hagenfeldt, Amanda Steen and Kabbo Iftekhayer (M&A), Ludvig Montan (Commercial Agreements), William Carlberg Johansson (Banking and Finance), Daniel Wendelsson, Sebastian Örndahl and Hanna Lemne (Regulatory), William Karo Persson (Employment), Wilma Hellman (Real Estate and Environment), Hayaat Ibrahim (Compliance) and Johanna Engström (Transaction Support Coordinator)

Related

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026

Vinge advises NEWS, a portfolio company of Litorina, in connection with the sale of Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG

Vinge advises Northern Environmental and Water Solutions AB (“NEWS”), a portfolio company of Litorina, in connection with the sale of the operating subsidiaries Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG (Vienna Stock Exchange: WIE). The transaction is expected to be completed in Q2 2026.
March 24, 2026

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026